Spring Pharmaceutical (CYIG) 10-K2015 FY Annual report

Filed: 13 Jul 15, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: abandon, Ace, agency, analyzed, bad, calendar, cetification, collateral, EITF, employee, exhausted, exit, extend, fee, franchised, hand, hierarchy, identical, long, lump, maximize, modeling, modify, observable, Oi, orderly, overdue, paritz, peer, plain, population, pre, PRITZ, QS, recurring, run, Sizhang, sluggish, stabilized, taxable, Tourism, Township, truckatum, truncaum, uncollectible, unique, unobservable, unpaid, unrestricted, unusual, Wanziyuan, WeiShiJianZi

Removed: abroad, Achievement, acquire, art, biloba, booked, Botanical, Chuanming, classification, closing, collectable, cooperative, creation, debt, deduction, derivative, EIT, enzyme, Europe, extracted, extraction, formulation, France, functional, Germany, Huoliyuann, identify, Immune, improper, influenced, Influenza, issuing, Jersey, large, largest, led, liquid, Liu, newspaper, North, obligation, occupy, offer, OTC, owner, package, Pink, preemptive, presented, Prevention, provision, ratio, remittance, returned, Safe, shipped, television, theFASB, trained, utilization, worldwide, Wutai, Yaguang

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

CYIG similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

EXHIBIT 32: Certificate pursuant to 18 U.S.C. ss. 1350

In connection with the Annual Report of China YCT International Group, Inc. (the “Company”) on Form 10K for the period ending March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

July 13, 2015	/s/ Yan Tinghe
	Yan Tinghe, Chief Executive Officer

July 13, 2015	/s/ Li Chuanmin
	Li Chuanmin, Chief Financial Officer